MEGAN MARTIN: Open Payments
NPI 1982976346 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 43 payments from 23 companies in 2025. Trend: 2023 $984 · 2024 $1,708 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $127 |
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Medtronic, Inc. | 1 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Antares Pharma, Inc. | 4 | $61 |
| Azurity Pharmaceuticals, Inc. | 3 | $46 |
| ABBVIE INC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $33 |
| Noven Therapeutics, LLC | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $30 |
Products named: VENASEAL, Kerendia, ENSITE PRECISION, XYOSTED, FREESTYLE LIBRE 3, AIRSUPRA, Xelstrym, Auvelity.
Industry payments across TX — which companies pay providers there.
